Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review.

Zaganjor I, Sekkarie A, Tsang BL, Williams J, Razzaghi H, Mulinare J, Sniezek JE, Cannon MJ, Rosenthal J.

PLoS One. 2016 Apr 11;11(4):e0151586. doi: 10.1371/journal.pone.0151586. eCollection 2016. Review.

2.

Self-Reported Prevalence of Alcohol Screening Among U.S. Adults.

Denny CH, Hungerford DW, McKnight-Eily LR, Green PP, Dang EP, Cannon MJ, Cheal NE, Sniezek JE.

Am J Prev Med. 2016 Mar;50(3):380-383. doi: 10.1016/j.amepre.2015.09.016. Epub 2015 Oct 29.

3.

Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages.

Cannon MJ, Ghosh D, Gujja S.

Vaccines (Basel). 2015 May 29;3(2):448-66. doi: 10.3390/vaccines3020448. Review.

4.

Seroprevalence of cytomegalovirus among children 1 to 5 years of age in the United States from the National Health and Nutrition Examination Survey of 2011 to 2012.

Lanzieri TM, Kruszon-Moran D, Amin MM, Bialek SR, Cannon MJ, Carroll MD, Dollard SC.

Clin Vaccine Immunol. 2015 Feb;22(2):245-7. doi: 10.1128/CVI.00697-14. Epub 2014 Dec 17.

5.

Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey.

Price SM, Bonilla E, Zador P, Levis DM, Kilgo CL, Cannon MJ.

BMC Womens Health. 2014 Nov 30;14:144. doi: 10.1186/s12905-014-0144-3.

6.

Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy cytomegalovirus-seropositive children.

Cannon MJ, Stowell JD, Clark R, Dollard PR, Johnson D, Mask K, Stover C, Wu K, Amin M, Hendley W, Guo J, Schmid DS, Dollard SC.

BMC Infect Dis. 2014 Nov 13;14:569. doi: 10.1186/s12879-014-0569-1.

7.

Cross-sectional study of cytomegalovirus shedding and immunological markers among seropositive children and their mothers.

Stowell JD, Mask K, Amin M, Clark R, Levis D, Hendley W, Lanzieri TM, Dollard SC, Cannon MJ.

BMC Infect Dis. 2014 Nov 12;14:568. doi: 10.1186/s12879-014-0568-2.

8.

Cytomegalovirus viral and antibody correlates in young children.

Dollard SC, Keyserling H, Radford K, Amin MM, Stowell J, Winter J, Schmid DS, Cannon MJ, Hyde TB.

BMC Res Notes. 2014 Nov 3;7:776. doi: 10.1186/1756-0500-7-776.

9.

Prevalence and characteristics of women at risk for an alcohol-exposed pregnancy (AEP) in the United States: estimates from the National Survey of Family Growth.

Cannon MJ, Guo J, Denny CH, Green PP, Miracle H, Sniezek JE, Floyd RL.

Matern Child Health J. 2015 Apr;19(4):776-82. doi: 10.1007/s10995-014-1563-3.

10.

Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?

Cannon MJ, Griffiths PD, Aston V, Rawlinson WD.

Rev Med Virol. 2014 Sep;24(5):291-307. doi: 10.1002/rmv.1790. Epub 2014 Apr 24. Review.

11.

Ovarian tumor ascites CD14+ cells suppress dendritic cell-activated CD4+ T-cell responses through IL-10 secretion and indoleamine 2,3-dioxygenase.

Goyne HE, Stone PJ, Burnett AF, Cannon MJ.

J Immunother. 2014 Apr;37(3):163-9. doi: 10.1097/CJI.0000000000000030.

12.

Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer.

Goyne HE, Cannon MJ.

Front Immunol. 2013 Nov 18;4:382. doi: 10.3389/fimmu.2013.00382. Review.

13.

Cytomegalovirus survival and transferability and the effectiveness of common hand-washing agents against cytomegalovirus on live human hands.

Stowell JD, Forlin-Passoni D, Radford K, Bate SL, Dollard SC, Bialek SR, Cannon MJ, Schmid DS.

Appl Environ Microbiol. 2014 Jan;80(2):455-61. doi: 10.1128/AEM.03262-13. Epub 2013 Nov 1.

14.
15.

Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen.

Cannon MJ, Goyne HE, Stone PJ, Macdonald LJ, James LE, Cobos E, Chiriva-Internati M.

Cancer Immunol Immunother. 2013 May;62(5):839-49. doi: 10.1007/s00262-013-1391-0. Epub 2013 Jan 25.

16.

Laboratory testing for cytomegalovirus among pregnant women in the United States: a retrospective study using administrative claims data.

Leung J, Cannon MJ, Grosse SD, Bialek SR.

BMC Infect Dis. 2012 Dec 3;12:334. doi: 10.1186/1471-2334-12-334.

17.

Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus.

Cannon MJ, Westbrook K, Levis D, Schleiss MR, Thackeray R, Pass RF.

Prev Med. 2012 May;54(5):351-7. doi: 10.1016/j.ypmed.2012.03.009. Epub 2012 Mar 21.

18.

Cytomegalovirus survival on common environmental surfaces: opportunities for viral transmission.

Stowell JD, Forlin-Passoni D, Din E, Radford K, Brown D, White A, Bate SL, Dollard SC, Bialek SR, Cannon MJ, Schmid DS.

J Infect Dis. 2012 Jan 15;205(2):211-4. doi: 10.1093/infdis/jir722. Epub 2011 Nov 23.

19.

National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.

Dollard SC, Staras SA, Amin MM, Schmid DS, Cannon MJ.

Clin Vaccine Immunol. 2011 Nov;18(11):1895-9. doi: 10.1128/CVI.05228-11. Epub 2011 Sep 14.

20.

CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend.

Kim KH, Greenfield WW, Cannon MJ, Coleman HN, Spencer HJ, Nakagawa M.

Cancer Immunol Immunother. 2012 Jan;61(1):63-70. doi: 10.1007/s00262-011-1092-5. Epub 2011 Aug 13.

Supplemental Content

Loading ...
Support Center